Singapore markets close in 2 hours 43 minutes

BioNexus Gene Lab Corp. (BGLC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.6096+0.0085 (+1.41%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
5,929
2,119
2,124
2,788
Total cash
5,929
2,119
2,124
2,788
Net receivables
799.674
2,868
3,357
3,997
Inventory
1,138
977.807
1,522
1,176
Total current assets
8,047
6,022
7,150
7,985
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
2,312
2,184
2,201
2,290
Accumulated depreciation
-659.115
-616.913
-525.631
-441.541
Net property, plant and equipment
1,653
1,567
1,676
1,848
Equity and other investments
1,700
1,151
749.027
281.668
Total non-current assets
3,353
2,718
2,425
2,130
Total assets
11,400
8,740
9,574
10,115
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
1,402
1,861
2,012
3,171
Deferred revenues
0
23.123
107.583
0
Total current liabilities
1,631
2,004
2,329
3,374
Non-current liabilities
Deferred tax liabilities
12.255
30.866
28.416
1.872
Total non-current liabilities
111.018
71.072
65.856
79.541
Total liabilities
1,742
2,075
2,395
3,453
Stockholders' equity
Common stock
17,191
10,930
10,780
10,780
Retained earnings
-1,844
1,156
1,512
760.787
Accumulated other comprehensive income
-677.294
-409.062
-100.262
133.684
Total stockholders' equity
9,658
6,665
7,180
6,662
Total liabilities and stockholders' equity
11,400
8,740
9,574
10,115